Please assess the completion status of the following clinical trial:

Trial Title: Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients above 18 years of age scheduled for cardiac surgery~* Excessive postoperative bleeding, more than 250 ml for one hour, or more than 150ml for two hours during the first four hours~Exclusion Criteria:~* Patients younger than 18 years of age~* Patients with a medical condition known to influence the hemostatic system~* Patients treated with clopidogrel or systemic steroids during the last week before surgery~* Patients with INR above 1.5~* Patients who are not able to give written informed concent~* Unstable patients who need other transfusion limits than in this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active treatment (Type: ACTIVE_COMPARATOR): Desmopressin 0.3 microgram/kg
- Placebo (Type: PLACEBO_COMPARATOR): NaCl 0.9%

Based on this trial design, predict the completion outcome and termination type (if applicable).